IRIS Accounts Production v26.1.10.61 07416554 Board of Directors 1.1.25 31.12.25 31.12.25 17.9.26 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074165542024-12-31074165542025-12-31074165542025-01-012025-12-31074165542023-12-31074165542024-01-012024-12-31074165542024-12-3107416554ns15:EnglandWales2025-01-012025-12-3107416554ns14:PoundSterling2025-01-012025-12-3107416554ns10:Director12025-01-012025-12-3107416554ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3107416554ns10:SmallEntities2025-01-012025-12-3107416554ns10:Audited2025-01-012025-12-3107416554ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3107416554ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3107416554ns10:FullAccounts2025-01-012025-12-310741655412025-01-012025-12-3107416554ns10:Director22025-01-012025-12-3107416554ns10:Director32025-01-012025-12-3107416554ns10:RegisteredOffice2025-01-012025-12-3107416554ns5:CurrentFinancialInstruments2025-12-3107416554ns5:CurrentFinancialInstruments2024-12-3107416554ns5:ShareCapital2025-12-3107416554ns5:ShareCapital2024-12-3107416554ns5:RetainedEarningsAccumulatedLosses2025-12-3107416554ns5:RetainedEarningsAccumulatedLosses2024-12-3107416554ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3107416554ns5:IntangibleAssetsOtherThanGoodwill2024-12-3107416554ns5:IntangibleAssetsOtherThanGoodwill2025-12-3107416554ns5:IntangibleAssetsOtherThanGoodwill2024-12-3107416554ns5:CurrentFinancialInstruments2025-01-012025-12-31
REGISTERED NUMBER: 07416554 (England and Wales)















Financial Statements for the Year Ended 31 December 2025

for

Yiling Ltd

Yiling Ltd (Registered number: 07416554)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Yiling Ltd

Company Information
for the Year Ended 31 December 2025







DIRECTORS: Ms X Li
C Li
S Zhao





REGISTERED OFFICE: 3rd Floor
9 St Clare Street
London
EC3N 1LQ





REGISTERED NUMBER: 07416554 (England and Wales)





AUDITORS: Shinewing Wilson Accountancy Limited
Chartered Certified Accountants
and Statutory Auditors
9 St Clare Street
London
EC3N 1LQ

Yiling Ltd (Registered number: 07416554)

Statement of Financial Position
31 December 2025

31.12.25 31.12.24
Notes £    £   
CURRENT ASSETS
Cash at bank 91,997 102,781

CREDITORS
Amounts falling due within one year 5 254,781 273,004
NET CURRENT LIABILITIES (162,784 ) (170,223 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(162,784

)

(170,223

)

CAPITAL AND RESERVES
Called up share capital 568,500 568,500
Retained earnings (731,284 ) (738,723 )
SHAREHOLDERS' FUNDS (162,784 ) (170,223 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2026 and were signed on its behalf by:





C Li - Director


Yiling Ltd (Registered number: 07416554)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Yiling Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
The company had net current liabilities of £163K at the balance sheet date, which is mainly owed to a fellow subsidiary, no short-term demand on the repayment of the funds is expected to be instructed. The ultimate parent company has confirmed in writing that it will continue to support the company for at least 12 months from the date of signing the financial statements. Based on this, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing the financial statements.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Yiling Ltd (Registered number: 07416554)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' of FRS 102 to all of its financial instruments.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the financial asset is measured at the present value of the future receipts discounted at a market rate of interest.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including trade and other payables, and loans from group undertakings, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest method.

Share capital
Financial instruments issued by the company are classified as equity only to the extent that they do not meet the definition of a financial liability or financial asset.

The company's ordinary shares are classified as equity instruments.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Yiling Ltd (Registered number: 07416554)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2025
and 31 December 2025 50,001
AMORTISATION
At 1 January 2025
and 31 December 2025 50,001
NET BOOK VALUE
At 31 December 2025 -
At 31 December 2024 -

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Amounts owed to group undertakings 247,640 265,864
Other creditors 7,141 7,140
254,781 273,004

Amounts owed to group undertakings are unsecured, interest free, have no fixed date of repayment and are repayable on demand.

6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Partha Ghosh (Senior Statutory Auditor)
for and on behalf of Shinewing Wilson Accountancy Limited

7. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Yiling Ltd (Registered number: 07416554)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

8. ULTIMATE CONTROLLING PARTY

The immediate parent company is Yiling Pharmaceutical Ltd, a company registered in P. R. China.

The ultimate parent undertaking and the largest group to consolidate these financial statements is Shijiazhuang Yiling Pharmaceutical Co., Ltd., a company registered in P.R. China and copies of the consolidated financial statements can be obtained from No.238 Tianshan Street, High-Tech Development Zone, Shijiazhuang, Hebei, China 050035.

The ultimate controlling party is Mr Y Wu.